Correlates of protective immunity to HCV and rational vaccine design: Admin Core
HCV 保护性免疫与合理疫苗设计的相关性:Admin Core
基本信息
- 批准号:10608106
- 负责人:
- 金额:$ 9.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-15 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAnnual ReportsB-LymphocytesBiometryBudgetsClinicalCollaborationsCommunitiesComplexConsultationsDatabasesDedicationsDevelopmentEnsureGoalsHepatitis CHepatitis C virusHumanImmune responseImmunityIndividualInfectionInfrastructureInstitutionIntellectual PropertyLeadershipMethodologyModificationOutcomePatientsPostdoctoral FellowProductivityPublicationsPublishingResearchResearch PersonnelResearch Project GrantsResolutionResource AllocationResourcesRoleScientistServicesTechnology TransferUnited States National Institutes of HealthUniversitiesVaccine DesignWorkantigen-specific T cellsdata managementdata sharingdesigngraduate studentmeetingsnonhuman primatenovel vaccinesprogramsresponsesymposiumvaccination strategy
项目摘要
Abstract
In this program, we propose to determine the correlates of protection in individuals that spontaneously clear
multiple HCV infection episodes. This will give highly valuable information for the design of next generation of
vaccines. Our goal to assess the role of antigen-specific T and B cell responses in infection outcome and to
generate an efficacious immune response by vaccination strategies in non-human primates based on emulating
successful resolution of natural re-exposure and re-infection in human patients.
This U19 proposal consists of 3 Projects and two Cores consisting of an Administrative Core A and a Clinical
Core B. The Administrative Core A will provide two functions: (i) provide overall administrative oversight and
support for the Program and (ii) provide biostatistical analyses and data management support for the individual
projects and Cores. This Administrative Core will be led by Dr. Grakoui at Emory University and will provide the
coordination necessary to make effective and efficient use of resources and intermediate results from this
collaborative effort. The primary function will be to facilitate scientific interactions between the Project leaders as
well as Core leaders. The administrative component will provide the leadership to ensure milestones are met,
assessment of the Core functions, modification of scientific goals, incorporation of any new collaborators,
decisions of ongoing prioritization and reallocation of resources. Critical decisions will be made in consultation
with the Project leaders and program official at NIH. The Administrative Core will file annual reports to the NIH.
The Administrative Core will maintain budgets and oversee any re-budgeting that is needed to meet program
goals. The biostatistics portion of the Administrative Core will provide data management and statistical support
for the three projects. In addition, the Biostatics portion will establish and maintain appropriate database,
management and analysis in response to investigators' requests. In order to provide services to meet the
analytical challenges the Core will include facilitating methodologies necessary for addressing complex statistical
issues encountered in various research projects. In addition, provide essential metrics between the clinicians,
scientists and biostatisticians. Having resources dedicated to the biostatistics and data management needs for
the research proposed here, will add enormous value to the quality and productivity of the research conducted
by the Investigators and to disseminate this information correctly to the scientific community.
摘要
在这个项目中,我们建议确定个人自发清除的保护相关因素,
多次HCV感染发作。这将为下一代的设计提供非常有价值的信息
疫苗。我们的目标是评估抗原特异性T和B细胞应答在感染结果中的作用,
在非人灵长类动物中通过疫苗接种策略产生有效的免疫应答
成功解决了人类患者的自然再暴露和再感染。
本U19提案包括3个项目和两个核心,包括行政核心A和临床核心B。
核心B。行政核心A将提供两项职能:㈠提供全面行政监督,
支持该计划;(ii)为个人提供生物统计分析和数据管理支持
项目和核心。该行政核心将由埃默里大学的Grakoui博士领导,并将提供
进行必要的协调,以有效和高效地利用资源和由此产生的中间成果
合作的努力。主要职能是促进项目负责人之间的科学互动,
作为核心领导者。行政部门将发挥领导作用,确保达到里程碑,
评估核心职能,修改科学目标,纳入任何新的合作者,
持续确定优先次序和重新分配资源的决定。关键决定将在协商中作出
与项目负责人和NIH的项目官员进行了交流。行政核心将向NIH提交年度报告。
行政核心将维持预算,并监督为满足计划所需的任何重新预算
目标.行政核心的生物统计部分将提供数据管理和统计支持
对于这三个项目。此外,生物统计部分将建立和维护适当的数据库,
根据调查人员的要求进行管理和分析。为了提供服务,以满足
分析挑战核心将包括促进必要的方法,以解决复杂的统计
在各种研究项目中遇到的问题。此外,提供临床医生之间的基本指标,
科学家和生物统计学家。拥有专门用于生物统计和数据管理需求的资源,
这里提出的研究将为所进行的研究的质量和生产力增加巨大的价值
研究者必须将这些信息正确地传播给科学界。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Arash Grakoui其他文献
Arash Grakoui的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Arash Grakoui', 18)}}的其他基金
Correlates of protective immunity to HCV and rational vaccine design
HCV 保护性免疫与合理疫苗设计的相关性
- 批准号:
10393614 - 财政年份:2021
- 资助金额:
$ 9.38万 - 项目类别:
Correlates of protective immunity to HCV and rational vaccine design: Admin Core
HCV 保护性免疫与合理疫苗设计的相关性:Admin Core
- 批准号:
10393615 - 财政年份:2021
- 资助金额:
$ 9.38万 - 项目类别:
Correlates of protective immunity to HCV and rational vaccine design
HCV 保护性免疫与合理疫苗设计的相关性
- 批准号:
10205764 - 财政年份:2021
- 资助金额:
$ 9.38万 - 项目类别:
Correlates of protective immunity to HCV and rational vaccine design: Project 2
HCV 保护性免疫与合理疫苗设计的相关性:项目 2
- 批准号:
10205768 - 财政年份:2021
- 资助金额:
$ 9.38万 - 项目类别:
Correlates of protective immunity to HCV and rational vaccine design: Project 2
HCV 保护性免疫与合理疫苗设计的相关性:项目 2
- 批准号:
10393618 - 财政年份:2021
- 资助金额:
$ 9.38万 - 项目类别:
Correlates of protective immunity to HCV and rational vaccine design: Project 2
HCV 保护性免疫与合理疫苗设计的相关性:项目 2
- 批准号:
10608110 - 财政年份:2021
- 资助金额:
$ 9.38万 - 项目类别:
Correlates of protective immunity to HCV and rational vaccine design
HCV 保护性免疫与合理疫苗设计的相关性
- 批准号:
10608105 - 财政年份:2021
- 资助金额:
$ 9.38万 - 项目类别:
Correlates of protective immunity to HCV and rational vaccine design: Admin Core
HCV 保护性免疫与合理疫苗设计的相关性:Admin Core
- 批准号:
10205765 - 财政年份:2021
- 资助金额:
$ 9.38万 - 项目类别:
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV
急性和慢性 HCV 期间抗原特异性 B 和 Tfh 反应的动态
- 批准号:
10063938 - 财政年份:2017
- 资助金额:
$ 9.38万 - 项目类别:
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV
急性和慢性 HCV 期间抗原特异性 B 和 Tfh 反应的动态
- 批准号:
10305612 - 财政年份:2017
- 资助金额:
$ 9.38万 - 项目类别:
相似海外基金
Culture change in international organizations: Exammining corporate annual reports of Japanese and US corporations
国际组织的文化变迁:审视日本和美国企业的年度报告
- 批准号:
20K01874 - 财政年份:2020
- 资助金额:
$ 9.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of the value of textual information in annual reports through natural language processing
通过自然语言处理分析年报文本信息的价值
- 批准号:
18K18566 - 财政年份:2018
- 资助金额:
$ 9.38万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Analysing Narrative Aspects of UK Preliminary Earnings Announcements and Annual Reports: Tools and Insights for Researchers and Regulators
分析英国初步收益公告和年度报告的叙述方面:研究人员和监管机构的工具和见解
- 批准号:
ES/R003904/1 - 财政年份:2017
- 资助金额:
$ 9.38万 - 项目类别:
Research Grant
The Design of Corporate Annual Reports in London, 1980-2000
1980-2000 年伦敦公司年度报告的设计
- 批准号:
1937453 - 财政年份:2017
- 资助金额:
$ 9.38万 - 项目类别:
Studentship
Making a database of statistical appendices to Annual Reports of the Poor Law Commissioners and those of the Poor Law Board and the analysis of the database.
建立济贫法专员和济贫法委员会年度报告的统计附录数据库,并对数据库进行分析。
- 批准号:
16530240 - 财政年份:2004
- 资助金额:
$ 9.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Econological Approach toward Annual Reports
年度报告的经济方法
- 批准号:
07630123 - 财政年份:1995
- 资助金额:
$ 9.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)